These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 28045062)
1. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx. Zhang Y; Sturgis EM; Li Y; Wei Q; Huang Z; Li G Sci Rep; 2017 Jan; 7():39765. PubMed ID: 28045062 [TBL] [Abstract][Full Text] [Related]
2. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx. Lu Z; Sturgis EM; Zhu L; Zhang H; Tao Y; Wei P; Wei Q; Li G Mol Carcinog; 2018 Mar; 57(3):361-369. PubMed ID: 29073727 [TBL] [Abstract][Full Text] [Related]
3. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy. Chen X; Sturgis EM; Wang C; Cao X; Li Y; Wei Q; Li G Oncotarget; 2016 Jun; 7(23):35015-25. PubMed ID: 27145460 [TBL] [Abstract][Full Text] [Related]
4. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx. Li Y; Sturgis EM; Zhu L; Cao X; Wei Q; Zhang H; Li G Mol Carcinog; 2017 Apr; 56(4):1335-1343. PubMed ID: 27864908 [TBL] [Abstract][Full Text] [Related]
5. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx. Zhu L; Sturgis EM; Zhang H; Lu Z; Tao Y; Wei Q; Li G Int J Cancer; 2017 Oct; 141(7):1355-1364. PubMed ID: 28646528 [TBL] [Abstract][Full Text] [Related]
6. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy. Zhang C; Sturgis EM; Zheng H; Song X; Wei P; Jin L; Chao L; Wei Q; Li G Int J Cancer; 2014 Apr; 134(8):1907-15. PubMed ID: 24122460 [TBL] [Abstract][Full Text] [Related]
7. Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy. Song X; Sturgis EM; Huang Z; Li X; Li C; Wei Q; Li G Carcinogenesis; 2014 Jan; 35(1):62-8. PubMed ID: 24104554 [TBL] [Abstract][Full Text] [Related]
8. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer. Zhang Y; Sturgis EM; Wei P; Liu H; Wang Z; Ma Y; Liu C; Gu KJ; Wei Q; Li G Mol Carcinog; 2019 Dec; 58(12):2276-2285. PubMed ID: 31513313 [TBL] [Abstract][Full Text] [Related]
9. GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy. Sun P; Wei P; Liu H; Wu J; Gross ND; Sikora AG; Wei Q; Shete S; Zafereo ME; Liu J; Li G EBioMedicine; 2023 Aug; 94():104722. PubMed ID: 37487414 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx. Jin L; Sturgis EM; Cao X; Song X; Salahuddin T; Wei Q; Li G FASEB J; 2013 Jun; 27(6):2496-503. PubMed ID: 23430974 [TBL] [Abstract][Full Text] [Related]
11. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy. Zhang F; Sturgis EM; Sun Y; Zhang Y; Wei Q; Zhang C; Zheng H; Li G Int J Cancer; 2015 Nov; 137(10):2454-61. PubMed ID: 25976983 [TBL] [Abstract][Full Text] [Related]
12. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Guan X; Sturgis EM; Song X; Liu Z; El-Naggar AK; Wei Q; Li G Cancer Lett; 2013 Apr; 330(2):233-40. PubMed ID: 23219900 [TBL] [Abstract][Full Text] [Related]
13. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer. Zhang Y; Sturgis EM; Sun Y; Sun C; Wei Q; Huang Z; Li G Eur J Cancer; 2015 Jul; 51(11):1415-23. PubMed ID: 25981582 [TBL] [Abstract][Full Text] [Related]
14. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx. Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232 [TBL] [Abstract][Full Text] [Related]
15. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck. Yu H; Huang YJ; Liu Z; Wang LE; Li G; Sturgis EM; Johnson DG; Wei Q Mol Carcinog; 2011 Sep; 50(9):697-706. PubMed ID: 21656578 [TBL] [Abstract][Full Text] [Related]
16. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer. Wang C; Sturgis EM; Chen X; Wei Q; Li G Oncotarget; 2016 Jun; 7(23):34472-9. PubMed ID: 27121322 [TBL] [Abstract][Full Text] [Related]
17. Tao Y; Sturgis EM; Huang Z; Wang Y; Wei P; Wang JR; Wei Q; Li G Clin Cancer Res; 2018 May; 24(9):2225-2233. PubMed ID: 29463556 [No Abstract] [Full Text] [Related]
18. Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Chen X; Sturgis EM; Lei D; Dahlstrom K; Wei Q; Li G Cancer Res; 2010 Sep; 70(18):7199-208. PubMed ID: 20736372 [TBL] [Abstract][Full Text] [Related]
19. p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers. Chen X; Sturgis EM; Etzel CJ; Wei Q; Li G Cancer; 2008 Dec; 113(12):3307-14. PubMed ID: 18988287 [TBL] [Abstract][Full Text] [Related]
20. Association of genetic variants with tumor HPV16 status and survival in squamous cell carcinoma of the oropharynx. Feng Y; Li Y; Zhang Y; Zheng H; Li G Oral Oncol; 2016 May; 56():78-83. PubMed ID: 27086490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]